Skip to main content
Top
Published in: Clinical Rheumatology 12/2018

01-12-2018 | Original Article

Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity

Authors: Rania M. Gamal, Nevin Hammam, Madeha M. Zakary, Marwa Mahmoud Abdelaziz, Mohamed Raouf Abdel Razek, Mona Sallam Embarek Mohamed, Yaser Emad, Mohamed Galal Elnaggar, Daniel E. Furst

Published in: Clinical Rheumatology | Issue 12/2018

Login to get access

Abstract

Rheumatoid arthritis (RA) is an inflammatory autoimmune polyarthritis with progressive destruction of the synovial joints associated with systemic manifestations. RA is characterized by infiltration of the synovial joints with inflammatory immune cells with premature immunosenescence. Shorter telomere length in the peripheral blood cells and increase in the oxidative stress have been detected in patients with RA. The aim of the present study was to study the association of markers of telomere shortening and oxidative stress with RA disease activity. Sixty-one RA patients and 15 healthy controls were enrolled in the study. Demographic data, clinical examination, and disease activity status were evaluated for the RA patients. Serum levels of chitinase and NAG (telomere markers) were determined by biochemical reactions using colloidal chitin and NAG as substrates, respectively. Nitric oxide and superoxide dismutase (oxidative stress markers) were determined colometrically and spectrophotometrically, respectively, in the sera of RA patients and controls. Results were correlated with disease activity. Indices of telomere shortening and oxidative markers were significantly higher in RA patients compared to controls. These indices were correlated with signs of disease activity (including number of swollen and tender joints, DAS-28, and inflammatory markers). Rheumatoid arthritis is a disease in which markers of telomere shortening and elevated oxidant stress correlate with disease activity.
Literature
1.
go back to reference Lajas C, Abasolo L, Bellajdel B, Hernández-García C, Carmona L, Vargas E, Lázaro P, Jover JA (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Care Res 49(1):64–70CrossRef Lajas C, Abasolo L, Bellajdel B, Hernández-García C, Carmona L, Vargas E, Lázaro P, Jover JA (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Care Res 49(1):64–70CrossRef
2.
go back to reference Andrews NP, Fujii H, Goronzy JJ, Weyand CM (2010) Telomeres and immunological diseases of aging. Gerontology 56(4):390–403CrossRef Andrews NP, Fujii H, Goronzy JJ, Weyand CM (2010) Telomeres and immunological diseases of aging. Gerontology 56(4):390–403CrossRef
3.
go back to reference Costenbader KH, Prescott J, Zee RY, De Vivo I (2011) Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease? Autoimmun Rev 10(9):569–573CrossRef Costenbader KH, Prescott J, Zee RY, De Vivo I (2011) Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease? Autoimmun Rev 10(9):569–573CrossRef
4.
go back to reference Weyand CM, Yang Z, Goronzy JJ (2014) T cell aging in rheumatoid arthritis. Curr Opin Rheumatol 26(1):93–100CrossRef Weyand CM, Yang Z, Goronzy JJ (2014) T cell aging in rheumatoid arthritis. Curr Opin Rheumatol 26(1):93–100CrossRef
5.
go back to reference Colmegna I, Weyand CM (2011) Haematopoietic stem and progenitor cells in rheumatoid arthritis. Rheumatology (Oxford, England) 50(2):252–260CrossRef Colmegna I, Weyand CM (2011) Haematopoietic stem and progenitor cells in rheumatoid arthritis. Rheumatology (Oxford, England) 50(2):252–260CrossRef
6.
go back to reference Bowers JS, Nelson MH, Majchrzak K, Bailey SR, Rohrer B, Kaiser ADM, et al. (2017) Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight 2 (5) Bowers JS, Nelson MH, Majchrzak K, Bailey SR, Rohrer B, Kaiser ADM, et al. (2017) Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight 2 (5)
7.
go back to reference Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM (2008) Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 58(4):990–1000CrossRef Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM (2008) Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 58(4):990–1000CrossRef
8.
go back to reference Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, Brecht M, Jeno P, Hall MN, Hager K, Manns MP, Hecker H, Ganser A, Dohner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL (2008) Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A 105(32):11299–11304CrossRef Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, Brecht M, Jeno P, Hall MN, Hager K, Manns MP, Hecker H, Ganser A, Dohner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL (2008) Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A 105(32):11299–11304CrossRef
9.
go back to reference Xiao F, Zheng X, Cui M, Shi G, Chen X, Li R, Song Z, Rudolph KL, Chen B, Ju Z (2011) Telomere dysfunction–related serological markers are associated with type 2 diabetes. Diabetes Care 34(10):2273–2278CrossRef Xiao F, Zheng X, Cui M, Shi G, Chen X, Li R, Song Z, Rudolph KL, Chen B, Ju Z (2011) Telomere dysfunction–related serological markers are associated with type 2 diabetes. Diabetes Care 34(10):2273–2278CrossRef
10.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569–2581 Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569–2581
11.
go back to reference Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48CrossRef Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48CrossRef
12.
go back to reference van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41(10):1845–1850CrossRef van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41(10):1845–1850CrossRef
13.
go back to reference Skrha J, Perusicova J, Stolba P, Stibor V, Pav J (1987) Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus. Clinica Chimica Acta; Int J Clin Chem 166(2–3):135–141CrossRef Skrha J, Perusicova J, Stolba P, Stibor V, Pav J (1987) Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus. Clinica Chimica Acta; Int J Clin Chem 166(2–3):135–141CrossRef
14.
go back to reference Lee YG, Chung KC, Wi SG, Lee JC, Bae HJ (2009) Purification and properties of a chitinase from Penicillium sp. LYG 0704. Protein Expr Purif 65(2):244–250CrossRef Lee YG, Chung KC, Wi SG, Lee JC, Bae HJ (2009) Purification and properties of a chitinase from Penicillium sp. LYG 0704. Protein Expr Purif 65(2):244–250CrossRef
15.
go back to reference Reissig JL, Strominger JL, Leloir LF (1955) A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem 217(2):959–966PubMed Reissig JL, Strominger JL, Leloir LF (1955) A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem 217(2):959–966PubMed
16.
go back to reference Van Bezooijen R, Que I, Ederveen A, Kloosterboer H, Papapoulos S, Lowik C (1998) Plasma nitrate + nitrite levels are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. J Endocrinol 159(1):27–34CrossRef Van Bezooijen R, Que I, Ederveen A, Kloosterboer H, Papapoulos S, Lowik C (1998) Plasma nitrate + nitrite levels are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. J Endocrinol 159(1):27–34CrossRef
17.
go back to reference Bannister JV, Calabrese L (2006) Assays for superoxide dismutase. Methods of Biochemical Analysis 32:279–312CrossRef Bannister JV, Calabrese L (2006) Assays for superoxide dismutase. Methods of Biochemical Analysis 32:279–312CrossRef
18.
go back to reference Grau A, Codony R, Rafecas M, Barroeta AC, Guardiola F (2000) Lipid hydroperoxide determination in dark chicken meat through a ferrous oxidation− xylenol orange method. J Agric Food Chem 48(9):4136–4143CrossRef Grau A, Codony R, Rafecas M, Barroeta AC, Guardiola F (2000) Lipid hydroperoxide determination in dark chicken meat through a ferrous oxidation− xylenol orange method. J Agric Food Chem 48(9):4136–4143CrossRef
19.
go back to reference Kordinas V, Ioannidis A, Chatzipanagiotou S (2016) The telomere/telomerase system in chronic inflammatory diseases. Cause or effect? Genes 7(9):60CrossRef Kordinas V, Ioannidis A, Chatzipanagiotou S (2016) The telomere/telomerase system in chronic inflammatory diseases. Cause or effect? Genes 7(9):60CrossRef
20.
go back to reference Hohensinner PJ, Goronzy Jö J, Weyand CM (2011) Telomere dysfunction, autoimmunity and aging Aging and Disease ;2(6):524–37 Hohensinner PJ, Goronzy Jö J, Weyand CM (2011) Telomere dysfunction, autoimmunity and aging Aging and Disease ;2(6):524–37
21.
go back to reference Zhang J, Rane G, Dai X, Shanmugam MK, Arfuso F, Samy RP, Lai MKP, Kappei D, Kumar AP, Sethi G (2016) Ageing and the telomere connection: an intimate relationship with inflammation. Ageing Res Rev 25:55–69CrossRef Zhang J, Rane G, Dai X, Shanmugam MK, Arfuso F, Samy RP, Lai MKP, Kappei D, Kumar AP, Sethi G (2016) Ageing and the telomere connection: an intimate relationship with inflammation. Ageing Res Rev 25:55–69CrossRef
22.
go back to reference Lin J, Sun J, Wang S, Milush JM, Baker CAR, Coccia M, Effros RB, Puterman E, Blackburn E, Prather AA, Epel E (2018) In vitro proinflammatory gene expression predicts in vivo telomere shortening: a preliminary study. Psychoneuroendocrinology 96:179–187CrossRef Lin J, Sun J, Wang S, Milush JM, Baker CAR, Coccia M, Effros RB, Puterman E, Blackburn E, Prather AA, Epel E (2018) In vitro proinflammatory gene expression predicts in vivo telomere shortening: a preliminary study. Psychoneuroendocrinology 96:179–187CrossRef
23.
go back to reference Shay JW, Zou Y, Hiyama E, Wright WE (2001) Telomerase and cancer. Hum Mol Genet 10(7):677–685CrossRef Shay JW, Zou Y, Hiyama E, Wright WE (2001) Telomerase and cancer. Hum Mol Genet 10(7):677–685CrossRef
24.
go back to reference Lee YHB, S C. Association between shortened telomere length and rheumatoid arthritis - a meta-analysis. Z Rheumatol. 2016; 0209 Lee YHB, S C. Association between shortened telomere length and rheumatoid arthritis - a meta-analysis. Z Rheumatol. 2016; 0209
25.
go back to reference Dehbi AR, TR; Broen, JC. Accelerated telomere shortening in rheumatic diseases: cause or consequence?. Expert Rev Clin Immunol 2013;9(12):1193–204CrossRef Dehbi AR, TR; Broen, JC. Accelerated telomere shortening in rheumatic diseases: cause or consequence?. Expert Rev Clin Immunol 2013;9(12):1193–204CrossRef
26.
go back to reference Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H (2004) Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Ann Rheum Dis 63(10):1250–1254CrossRef Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H (2004) Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Ann Rheum Dis 63(10):1250–1254CrossRef
27.
go back to reference Kawashima M, Kawakita T, Maida Y, Kamoi M, Ogawa Y, Shimmura S et al (2011) Comparison of telomere length and association with progenitor cell markers in lacrimal gland between Sjögren syndrome and non-Sjögren syndrome dry eye patients. Mol Vis 17:1397PubMedPubMedCentral Kawashima M, Kawakita T, Maida Y, Kamoi M, Ogawa Y, Shimmura S et al (2011) Comparison of telomere length and association with progenitor cell markers in lacrimal gland between Sjögren syndrome and non-Sjögren syndrome dry eye patients. Mol Vis 17:1397PubMedPubMedCentral
28.
go back to reference Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet A-S, Hermine O (2010) The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev 9(10):646–651CrossRef Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet A-S, Hermine O (2010) The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev 9(10):646–651CrossRef
29.
go back to reference Wallace D, Salonen E-M, Avaniss-Aghajani E, Morris R, Metzger A, Pashinian N (2000) Anti-telomere antibodies in systemic lupus erythematosus: a new ELISA test for anti-DNA with potential pathogenetic implications. Lupus 9(5):328–332CrossRef Wallace D, Salonen E-M, Avaniss-Aghajani E, Morris R, Metzger A, Pashinian N (2000) Anti-telomere antibodies in systemic lupus erythematosus: a new ELISA test for anti-DNA with potential pathogenetic implications. Lupus 9(5):328–332CrossRef
30.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRef
31.
go back to reference Fessler J, Raicht A, Husic R, Ficjan A, Schwarz C, Duftner C et al (2017) novel senescent regulatory T-cell subset with impaired suppressive function in rheumatoid arthritis. Front Immunol 8:300CrossRef Fessler J, Raicht A, Husic R, Ficjan A, Schwarz C, Duftner C et al (2017) novel senescent regulatory T-cell subset with impaired suppressive function in rheumatoid arthritis. Front Immunol 8:300CrossRef
32.
go back to reference Lindstrom TM, Robinson WH (2010) Rheumatoid arthritis: a role for immunosenescence? J Am Geriatr Soc 58(8):1565–1575CrossRef Lindstrom TM, Robinson WH (2010) Rheumatoid arthritis: a role for immunosenescence? J Am Geriatr Soc 58(8):1565–1575CrossRef
33.
go back to reference Steer SE, Williams FM, Kato B, Gardner JP, Norman PJ, Hall MA, Kimura M, Vaughan R, Aviv A, Spector TD (2007) Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 66(4):476–480CrossRef Steer SE, Williams FM, Kato B, Gardner JP, Norman PJ, Hall MA, Kimura M, Vaughan R, Aviv A, Spector TD (2007) Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 66(4):476–480CrossRef
34.
go back to reference Aviv A (2002) Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med (Berlin, Germany) 80(11):689–695CrossRef Aviv A (2002) Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med (Berlin, Germany) 80(11):689–695CrossRef
35.
go back to reference Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS (2009) Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 114(11):2236–2243CrossRef Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS (2009) Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 114(11):2236–2243CrossRef
36.
go back to reference Barrett EL, Richardson DS (2011) Sex differences in telomeres and lifespan. Aging Cell 10(6):913–921CrossRef Barrett EL, Richardson DS (2011) Sex differences in telomeres and lifespan. Aging Cell 10(6):913–921CrossRef
37.
go back to reference Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, Celotta G, Cassibba N, Pennisi G, Caschetto S (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53(1):77–82CrossRef Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, Celotta G, Cassibba N, Pennisi G, Caschetto S (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53(1):77–82CrossRef
38.
go back to reference Vural P, Akgül C, Canbaz M (2005) Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42(3):220–223CrossRef Vural P, Akgül C, Canbaz M (2005) Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42(3):220–223CrossRef
39.
go back to reference Yagi K (1997) Female hormones act as natural antioxidants--a survey of our research. Acta Biochim Pol 44(4):701–709PubMed Yagi K (1997) Female hormones act as natural antioxidants--a survey of our research. Acta Biochim Pol 44(4):701–709PubMed
40.
go back to reference Yamanishi Y, Hiyama K, Maeda H, Ishioka S, Murakami T, Hiyama E, Kurose Y, Shay JW, Yamakido M (1998) Telomerase activity in rheumatoid synovium correlates with the mononuclear cell infiltration level and disease aggressiveness of rheumatoid arthritis. J Rheumatol 25(2):214–220PubMed Yamanishi Y, Hiyama K, Maeda H, Ishioka S, Murakami T, Hiyama E, Kurose Y, Shay JW, Yamakido M (1998) Telomerase activity in rheumatoid synovium correlates with the mononuclear cell infiltration level and disease aggressiveness of rheumatoid arthritis. J Rheumatol 25(2):214–220PubMed
41.
go back to reference Adamali HI, Delgado CM, Stock C, Lindhal GE, Molyneaux PL, Russell AM, et al. Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease. 2012 Adamali HI, Delgado CM, Stock C, Lindhal GE, Molyneaux PL, Russell AM, et al. Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease. 2012
42.
go back to reference Fujii H, Shao L, Colmegna I, Goronzy JJ, Weyand CM (2009) Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci 106(11):4360–4365CrossRef Fujii H, Shao L, Colmegna I, Goronzy JJ, Weyand CM (2009) Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci 106(11):4360–4365CrossRef
43.
go back to reference Steer SE, Williams FMK, Kato B, Gardner JP, Norman PJ, Hall MA, Kimura M, Vaughan R, Aviv A, Spector TD (2007) Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 66(4):476–480CrossRef Steer SE, Williams FMK, Kato B, Gardner JP, Norman PJ, Hall MA, Kimura M, Vaughan R, Aviv A, Spector TD (2007) Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 66(4):476–480CrossRef
44.
go back to reference Lin J, Epel ES, Blackburn EH (2009) Telomeres, telomerase, stress, and aging. Handbook of Neuroscience for the Behavioral Sciences Lin J, Epel ES, Blackburn EH (2009) Telomeres, telomerase, stress, and aging. Handbook of Neuroscience for the Behavioral Sciences
45.
go back to reference Desai PB, Manjunath S, Kadi S, Chetana K, Vanishree J (2010) Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study. Eur Rev Med Pharmacol Sci 14(11):959–967PubMed Desai PB, Manjunath S, Kadi S, Chetana K, Vanishree J (2010) Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study. Eur Rev Med Pharmacol Sci 14(11):959–967PubMed
46.
go back to reference Datta S, Kundu S, Ghosh P, De S, Ghosh A, Chatterjee M (2014) Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clin Rheumatol 33(11):1557–1564CrossRef Datta S, Kundu S, Ghosh P, De S, Ghosh A, Chatterjee M (2014) Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clin Rheumatol 33(11):1557–1564CrossRef
47.
go back to reference Alver A, Şentürk A, Çakirbay H, Menteşe A, Gökmen F, Keha EE, Uçar F (2011) Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clin Biochem 44(17):1385–1389CrossRef Alver A, Şentürk A, Çakirbay H, Menteşe A, Gökmen F, Keha EE, Uçar F (2011) Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clin Biochem 44(17):1385–1389CrossRef
48.
go back to reference Staroń A, Mąkosa G, Koter-Michalak M (2012) Oxidative stress in erythrocytes from patients with rheumatoid arthritis. Rheumatol Int 32(2):331–334CrossRef Staroń A, Mąkosa G, Koter-Michalak M (2012) Oxidative stress in erythrocytes from patients with rheumatoid arthritis. Rheumatol Int 32(2):331–334CrossRef
49.
go back to reference Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, EL-SOROUGY IM, Abdou MS (2011) Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 14(4):325–331CrossRef Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, EL-SOROUGY IM, Abdou MS (2011) Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 14(4):325–331CrossRef
50.
go back to reference Kamanlı A, Nazıroğlu M, Aydılek N, Hacıevlıyagil C (2004) Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 22(1):53–57CrossRef Kamanlı A, Nazıroğlu M, Aydılek N, Hacıevlıyagil C (2004) Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 22(1):53–57CrossRef
Metadata
Title
Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity
Authors
Rania M. Gamal
Nevin Hammam
Madeha M. Zakary
Marwa Mahmoud Abdelaziz
Mohamed Raouf Abdel Razek
Mona Sallam Embarek Mohamed
Yaser Emad
Mohamed Galal Elnaggar
Daniel E. Furst
Publication date
01-12-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4318-5

Other articles of this Issue 12/2018

Clinical Rheumatology 12/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.